|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000136213 |
Summary for CHST12 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000136213 | Gene symbol | CHST12 |
| Gene name | carbohydrate sulfotransferase 12 | |
| HGNC | 17423 | |
| Entrez ID | 55501 | |
| Gene type | protein_coding | |
| Synonyms | CHST12|C4S-2|C4ST2 | |
| UniProtAcc | Q9NRB3 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CHST12 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for CHST12 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CHST12 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| THCA | cg18137244 | chr7:2404575 | CGI:chr7:2403157-2404376 | promoter,gene body | 2.37e-01 | 3.55e-01 | -2.75e+00 | 6.03e-03 | 1.15e-02 | -1.19e-01 |
| HNSC | cg18137244 | chr7:2404575 | CGI:chr7:2403157-2404376 | promoter,gene body | 2.67e-01 | 1.58e-01 | 3.05e+00 | 2.32e-03 | 3.71e-03 | 1.08e-01 |
| LUSC | cg22107476 | chr7:2403025 | CGI:chr7:2403157-2404376 | promoter | 1.67e-01 | 2.82e-01 | -4.39e+00 | 1.16e-05 | 5.26e-04 | -1.15e-01 |
| LUSC | cg10152449 | chr7:2404899 | CGI:chr7:2403157-2404376 | promoter,gene body | 7.59e-01 | 5.66e-01 | 3.67e+00 | 2.39e-04 | 1.07e-03 | 1.93e-01 |
| BLCA | cg22107476 | chr7:2403025 | CGI:chr7:2403157-2404376 | promoter | 1.47e-01 | 2.84e-01 | -4.90e+00 | 9.37e-07 | 6.20e-05 | -1.37e-01 |
| ESCA | cg18137244 | chr7:2404575 | CGI:chr7:2403157-2404376 | promoter,gene body | 3.22e-01 | 1.89e-01 | 2.19e+00 | 2.82e-02 | 4.32e-02 | 1.34e-01 |
| ESCA | cg10152449 | chr7:2404899 | CGI:chr7:2403157-2404376 | promoter,gene body | 7.86e-01 | 6.20e-01 | 2.67e+00 | 7.58e-03 | 3.54e-02 | 1.67e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg18137244 | chr7:2404575 | CGI:chr7:2403157-2404376 | promoter,gene body | 3.00e-01 | 1.09e-01 | 1.06e+01 | 2.43e-26 | 2.35e-25 | 1.90e-01 |
| KIRC | cg22107476 | chr7:2403025 | CGI:chr7:2403157-2404376 | promoter | 1.85e-01 | 2.92e-01 | -2.90e+00 | 3.69e-03 | 9.14e-03 | -1.08e-01 |
Top |
Exon skipping events with PSI in TCGA for CHST12 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CHST12 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| KIRC | CHST12-002 | chr7_2434974_+ | 2.19e-01 | 2.56e-01 | -2.37e+00 | 1.79e-02 | 4.41e-02 | -3.69e-02 |
| LUAD | CHST12-002 | chr7_2435095_+ | 2.55e-01 | 1.97e-01 | 2.11e+00 | 3.52e-02 | 4.46e-02 | 5.74e-02 |
| LUAD | CHST12-004 | chr7_2447735_+ | 2.17e-01 | 3.10e-01 | -2.15e+00 | 3.18e-02 | 4.37e-02 | -9.32e-02 |
| LUAD | CHST12-002 | chr7_2448051_+ | 1.93e-01 | 2.58e-01 | -1.97e+00 | 4.85e-02 | 4.94e-02 | -6.48e-02 |
| LGG | CHST12-002 | chr7_2434645_+ | 2.41e-01 | 1.78e-01 | 2.07e+00 | 3.83e-02 | 4.81e-02 | 6.26e-02 |
| STAD | CHST12-201 | chr7_2419521_+ | 4.42e-01 | 2.57e-01 | 2.20e+00 | 2.78e-02 | 4.96e-02 | 1.85e-01 |
| PCPG | CHST12-002 | chr7_2434832_+ | 2.68e-01 | 1.91e-01 | 2.37e+00 | 1.76e-02 | 4.98e-02 | 7.66e-02 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| BRCA | CHST12-201 | chr7_2434482_+ | 1.50e-01 | 2.02e-01 | -2.27e+00 | 2.29e-02 | 2.73e-02 | -5.19e-02 |
| BRCA | CHST12-002 | chr7_2434886_+ | 2.86e-01 | 2.01e-01 | 2.79e+00 | 5.33e-03 | 8.24e-03 | 8.49e-02 |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CHST12 |
| TFs related to CHST12. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHST12 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CHST12 |
| RBPs related to ES in CHST12. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CHST12 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs144022506 | chr7:12039864:T:C | - | 0.210625951063404 | 0.032653185339507 | PAAD | Female-baised eQTL |
| rs6973780 | chr7:10053853:A:G | - | 0.0730232267994574 | 0.0134358501006626 | LUAD | Female-baised eQTL |
| rs6954245 | chr7:10053711:C:T | - | 0.0705410945332278 | 0.016913625843167 | LUAD | Female-baised eQTL |
| rs10241744 | chr7:10052305:C:A | - | 0.0702084270780997 | 0.0177170936420687 | LUAD | Female-baised eQTL |
| rs10259886 | chr7:10052299:T:A | - | 0.070301887151298 | 0.017725629817263 | LUAD | Female-baised eQTL |
| rs10261285 | chr7:10049845:G:C | - | 0.0692757016726259 | 0.0183073075502426 | LUAD | Female-baised eQTL |
| rs4720867 | chr7:10050499:G:C | - | 0.0692757016726259 | 0.0183073075502426 | LUAD | Female-baised eQTL |
| rs10241626 | chr7:10052238:C:T | - | 0.0703337758237522 | 0.0188528963963896 | LUAD | Female-baised eQTL |
| rs6969535 | chr7:10053589:A:C | - | 0.0695254235617953 | 0.0192781352570436 | LUAD | Female-baised eQTL |
| rs10232598 | chr7:10049718:C:G | - | 0.0691611145536931 | 0.020290376290378 | LUAD | Female-baised eQTL |
| rs10232868 | chr7:10049998:C:T | - | 0.0691611145536931 | 0.020290376290378 | LUAD | Female-baised eQTL |
| rs6976933 | chr7:10051338:C:G | - | 0.0691611145536931 | 0.020290376290378 | LUAD | Female-baised eQTL |
| rs151044339 | chr7:10051732:A:C | - | 0.0691611145536931 | 0.020290376290378 | LUAD | Female-baised eQTL |
| rs10256248 | chr7:10051860:A:G | - | 0.0691611145536931 | 0.020290376290378 | LUAD | Female-baised eQTL |
| rs10241397 | chr7:10052071:C:A | - | 0.0691611145536931 | 0.020290376290378 | LUAD | Female-baised eQTL |
| rs7778537 | chr7:10052542:C:T | - | 0.0691611145536931 | 0.020290376290378 | LUAD | Female-baised eQTL |
| rs10256132 | chr7:10051795:A:G | - | 0.0690778257174566 | 0.0211210272061846 | LUAD | Female-baised eQTL |
| rs7804793 | chr7:10052800:T:C | - | 0.0687709777166014 | 0.0218933756401219 | LUAD | Female-baised eQTL |
| rs6949608 | chr7:10053320:C:T | - | 0.0674937898062239 | 0.0270696552177919 | LUAD | Female-baised eQTL |
| rs6949609 | chr7:10053322:C:T | - | 0.0674937898062239 | 0.0270696552177919 | LUAD | Female-baised eQTL |
| rs6976019 | chr7:10050788:C:G | - | 0.0664621717675104 | 0.0331130840200801 | LUAD | Female-baised eQTL |
| rs10246999 | chr7:10041684:G:C | - | 0.0645356463488277 | 0.0334599162035381 | LUAD | Female-baised eQTL |
| rs10249087 | chr7:4364494:A:G | - | 0.0581136180008067 | 0.0338303649576708 | LUAD | Female-baised eQTL |
| rs12666770 | chr7:9526395:A:G | - | 0.0593476250940022 | 0.0378631499843341 | LUAD | Female-baised eQTL |
| rs10237076 | chr7:10042113:A:G | - | 0.063003494001288 | 0.039441859499586 | LUAD | Female-baised eQTL |
| rs10253042 | chr7:10047897:G:A | - | 0.0629601148946903 | 0.0439480571035834 | LUAD | Female-baised eQTL |
| rs6954962 | chr7:10047699:G:A | - | 0.0623405003991917 | 0.0450959722599968 | LUAD | Female-baised eQTL |
| rs12386620 | chr7:10042325:T:C | - | 0.0625898300491849 | 0.0451872854073128 | LUAD | Female-baised eQTL |
| rs12386621 | chr7:10042378:T:G | - | 0.0625898300491849 | 0.0451872854073128 | LUAD | Female-baised eQTL |
| rs917173 | chr7:10042546:T:G | - | 0.0625898300491849 | 0.0451872854073128 | LUAD | Female-baised eQTL |
| rs6962642 | chr7:10051355:T:C | - | 0.0646057685741071 | 0.0453089103674256 | LUAD | Female-baised eQTL |
| rs10240254 | chr7:10048383:A:G | - | 0.0624108576902828 | 0.0470844962726515 | LUAD | Female-baised eQTL |
| rs6945657 | chr7:10047887:T:C | - | 0.0626867284346643 | 0.0487419862060615 | LUAD | Female-baised eQTL |
| rs6958999 | chr7:10047889:G:C | - | 0.0626867284346643 | 0.0487419862060615 | LUAD | Female-baised eQTL |
| rs10224574 | chr7:10047895:C:A | - | 0.0626867284346643 | 0.0487419862060615 | LUAD | Female-baised eQTL |
| rs917171 | chr7:10042749:C:G | - | 0.0609296812877876 | 0.0494683161448568 | LUAD | Female-baised eQTL |
| rs13226817 | chr7:10044262:C:A | - | 0.0618441123018205 | 0.0499083659647456 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs56397878 | chr7:89835:C:T | - | -0.0406410355633095 | 0.0398351133124805 | HNSC | Male-baised eQTL |
| rs140854768 | chr7:8300607:T:A | - | 0.0714309824857173 | 0.0389294179851944 | STAD | Male-baised eQTL |
| rs146935416 | chr7:8302078:A:T | - | 0.0712484269837688 | 0.0438612268731259 | STAD | Male-baised eQTL |
| rs10258717 | chr7:12292025:A:G | - | -0.0405842367008132 | 0.0178396791822564 | KIRC | Male-baised eQTL |
| rs12536652 | chr7:11872813:G:A | - | 0.122097861010886 | 0.00176803138088687 | BLCA | Male-baised eQTL |
| rs4722092 | chr7:2807372:C:T | - | 0.0713283081082641 | 0.00341600631240028 | BLCA | Male-baised eQTL |
| rs11766172 | chr7:9279376:C:T | - | -0.11021926386882 | 0.00357213892135317 | BLCA | Male-baised eQTL |
| rs10271477 | chr7:9279770:T:C | - | -0.11021926386882 | 0.00357213892135317 | BLCA | Male-baised eQTL |
| rs1406626 | chr7:9280313:A:G | - | -0.11021926386882 | 0.00357213892135317 | BLCA | Male-baised eQTL |
| rs13234026 | chr7:5486272:A:G | - | 0.0531085996784702 | 0.0037274841499718 | BLCA | Male-baised eQTL |
| rs4352753 | chr7:5487592:C:A | - | 0.0518543621250536 | 0.00411821341262658 | BLCA | Male-baised eQTL |
| rs1285384 | chr7:9275110:T:C | - | -0.107609126792979 | 0.00440274774684551 | BLCA | Male-baised eQTL |
| rs1285391 | chr7:9269791:G:A | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs1285390 | chr7:9270631:C:T | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs1285385 | chr7:9275070:T:C | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs6975482 | chr7:9276443:G:T | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs6942825 | chr7:9276707:C:G | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs6463901 | chr7:9277185:T:A | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs2178346 | chr7:9289821:G:T | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs10246847 | chr7:9290996:G:A | - | -0.107344796318201 | 0.00458163605107157 | BLCA | Male-baised eQTL |
| rs2581516 | chr7:9263364:G:T | - | -0.107083113567363 | 0.00478312398550132 | BLCA | Male-baised eQTL |
| rs13241226 | chr7:5504687:G:A | - | 0.0573830245458894 | 0.00564993392036328 | BLCA | Male-baised eQTL |
| rs7787662 | chr7:818298:G:C | - | -0.0578695392697003 | 0.00966126228256826 | BLCA | Male-baised eQTL |
| rs10246812 | chr7:792292:C:T | - | 0.0584712746363588 | 0.0130118813041646 | BLCA | Male-baised eQTL |
| rs28516975 | chr7:803790:C:G | - | 0.0565759319707429 | 0.0165858604395234 | BLCA | Male-baised eQTL |
| rs28553889 | chr7:803816:G:A | - | 0.0565759319707429 | 0.0165858604395234 | BLCA | Male-baised eQTL |
| rs10246069 | chr7:791734:C:T | - | 0.0572626185759005 | 0.0168932453609474 | BLCA | Male-baised eQTL |
| rs73038160 | chr7:794456:C:T | - | 0.0563031324768262 | 0.0180340728665768 | BLCA | Male-baised eQTL |
| rs139178665 | chr7:795032:C:G | - | 0.0563031324768262 | 0.0180340728665768 | BLCA | Male-baised eQTL |
| rs10950832 | chr7:866991:A:G | - | -0.0543690985321939 | 0.0183191904832431 | BLCA | Male-baised eQTL |
| rs4302742 | chr7:795777:G:A | - | 0.0560897771493513 | 0.0185075207189304 | BLCA | Male-baised eQTL |
| rs56106358 | chr7:801323:T:C | - | 0.0562054024296804 | 0.0204138384026848 | BLCA | Male-baised eQTL |
| rs2699135 | chr7:9243845:C:G | - | -0.0891381924538628 | 0.0206623051708624 | BLCA | Male-baised eQTL |
| rs2581520 | chr7:9258855:G:A | - | -0.0899599246545714 | 0.0206638884760674 | BLCA | Male-baised eQTL |
| rs2581519 | chr7:9259794:C:G | - | -0.0899599246545714 | 0.0206638884760674 | BLCA | Male-baised eQTL |
| rs10479923 | chr7:799940:C:T | - | 0.0557318344596508 | 0.0208464745716517 | BLCA | Male-baised eQTL |
| rs1919790 | chr7:9244112:T:C | - | -0.0898354985794675 | 0.0210510265088765 | BLCA | Male-baised eQTL |
| rs1881768 | chr7:9247108:C:T | - | -0.0898354985794675 | 0.0210510265088765 | BLCA | Male-baised eQTL |
| rs1529243 | chr7:9247323:T:C | - | -0.0898354985794675 | 0.0210510265088765 | BLCA | Male-baised eQTL |
| rs1881769 | chr7:9247378:G:C | - | -0.0898354985794675 | 0.0210510265088765 | BLCA | Male-baised eQTL |
| rs1529240 | chr7:9249097:T:A | - | -0.0898354985794675 | 0.0210510265088765 | BLCA | Male-baised eQTL |
| rs1529239 | chr7:9249249:A:C | - | -0.0898354985794675 | 0.0210510265088765 | BLCA | Male-baised eQTL |
| rs2581508 | chr7:9255113:C:A | - | -0.0898354985794675 | 0.0210510265088765 | BLCA | Male-baised eQTL |
| rs12702919 | chr7:9510942:A:C | - | -0.0448711246609383 | 0.0223037108897957 | BLCA | Male-baised eQTL |
| rs6943357 | chr7:8148193:T:C | - | -0.0740683070641804 | 0.0227754399430048 | BLCA | Male-baised eQTL |
| rs10950370 | chr7:11870770:G:A | - | 0.0604901439461554 | 0.022866281086255 | BLCA | Male-baised eQTL |
| rs73038163 | chr7:795161:T:G | - | 0.0551287714244721 | 0.0230851565568316 | BLCA | Male-baised eQTL |
| rs1681300 | chr7:10950685:G:A | - | 0.0454713258256472 | 0.0236857473324371 | BLCA | Male-baised eQTL |
| rs4256502 | chr7:841643:G:T | - | -0.0543487281553711 | 0.024185148767435 | BLCA | Male-baised eQTL |
| rs6461400 | chr7:849077:A:G | - | -0.0543487281553711 | 0.024185148767435 | BLCA | Male-baised eQTL |
| rs4416731 | chr7:854000:G:A | - | -0.0543487281553711 | 0.024185148767435 | BLCA | Male-baised eQTL |
| rs10950881 | chr7:877041:T:C | - | -0.053930975114634 | 0.0246072472684677 | BLCA | Male-baised eQTL |
| rs56137647 | chr7:798576:G:C | - | 0.0547329080917604 | 0.0246300809194922 | BLCA | Male-baised eQTL |
| rs10479763 | chr7:799611:G:A | - | 0.0547329080917604 | 0.0246300809194922 | BLCA | Male-baised eQTL |
| rs28534975 | chr7:11874564:G:A | - | 0.060069648967675 | 0.0281949377830448 | BLCA | Male-baised eQTL |
| rs10156131 | chr7:8147810:T:C | - | -0.0754894503165632 | 0.029213988554165 | BLCA | Male-baised eQTL |
| rs2165270 | chr7:9246338:T:C | - | -0.0793073523684048 | 0.030476551280207 | BLCA | Male-baised eQTL |
| rs2699122 | chr7:9257067:C:T | - | -0.0642111692164355 | 0.0358015637908459 | BLCA | Male-baised eQTL |
| rs4548084 | chr7:9519964:G:C | - | -0.0424807203353336 | 0.0378006296550837 | BLCA | Male-baised eQTL |
| rs10452828 | chr7:9520079:T:G | - | -0.04253667155368 | 0.0380786512425486 | BLCA | Male-baised eQTL |
| rs1505310 | chr7:9527894:G:A | - | -0.0493077965287479 | 0.0444784759677347 | BLCA | Male-baised eQTL |
| rs67461903 | chr7:3278168:T:C | - | 0.080627180102659 | 0.0159469793102627 | LUAD | Male-baised eQTL |
| rs68092516 | chr7:3278028:C:T | - | 0.0785531904371813 | 0.0202994558372381 | LUAD | Male-baised eQTL |
| rs1961404 | chr7:3278843:G:A | - | 0.0785057536988368 | 0.0203571074847457 | LUAD | Male-baised eQTL |
| rs57427044 | chr7:3282805:G:A | - | 0.0785057536988368 | 0.0203571074847457 | LUAD | Male-baised eQTL |
| rs2222408 | chr7:3439950:T:C | - | 0.0694911141286655 | 0.0283152773721864 | LUAD | Male-baised eQTL |
| rs66664718 | chr7:3477624:C:T | - | 0.069805012467586 | 0.0293588886849303 | LUAD | Male-baised eQTL |
| rs10224861 | chr7:9782098:C:A | - | 0.0481662436500154 | 0.0360889562713821 | LUAD | Male-baised eQTL |
| rs55716539 | chr7:3503340:A:T | - | 0.0906750571677308 | 0.0363849496620209 | LUAD | Male-baised eQTL |
| rs17133485 | chr7:3503360:C:G | - | 0.0906750571677308 | 0.0363849496620209 | LUAD | Male-baised eQTL |
| rs118173112 | chr7:3291276:A:G | - | 0.0741112646231889 | 0.0494364404174438 | LUAD | Male-baised eQTL |
| rs17133406 | chr7:3475744:A:G | - | 0.0759831892838009 | 0.0496021976870583 | LUAD | Male-baised eQTL |
| rs4724182 | chr7:4915659:C:G | - | -0.0613297002936777 | 0.00907769595006863 | COAD | Male-baised eQTL |
| rs2881078 | chr7:4915176:T:C | - | -0.0611265699823011 | 0.00945499243836541 | COAD | Male-baised eQTL |
| rs876408 | chr7:4952655:C:T | - | 0.061685440173802 | 0.0104274507650649 | COAD | Male-baised eQTL |
| rs6463168 | chr7:4914657:A:G | - | -0.0600439638827785 | 0.0111423429019651 | COAD | Male-baised eQTL |
| rs56671906 | chr7:4913766:A:G | - | -0.0598732703439623 | 0.0112491623372236 | COAD | Male-baised eQTL |
| rs6946278 | chr7:4914090:G:A | - | -0.0591841158634772 | 0.0120649052441662 | COAD | Male-baised eQTL |
| rs6947382 | chr7:4914013:C:A | - | -0.0582348564013206 | 0.0136521170488931 | COAD | Male-baised eQTL |
| rs6979698 | chr7:4913443:G:A | - | -0.058686981240096 | 0.0139287535128413 | COAD | Male-baised eQTL |
| rs28676920 | chr7:4912651:A:G | - | -0.0560443816185876 | 0.016757236245991 | COAD | Male-baised eQTL |
| rs6951799 | chr7:4911584:A:G | - | -0.0553836364212702 | 0.0187795074253808 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000136213 |
| CpG Site: cg03573679 | |
| Position to Gene: gene,enhancer | |
| Male Effect: -0.401268402461357 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg03573679 | chr7:2406092 | gene,enhancer | -0.401268402461357 | 8.02640382720068e-10 | -0.4519483847118912 | 1.2654835320005824e-12 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CHST12 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
